X
Practical tool to address real patient information needs
https://pharmaphorum.com/views-analysis-patients/patient-information-needs-practical-tools/
AbbVie
New Speakers from Roche & Imperial College announced for SMi’s ADMET Event
Roche to join ADMET conference this July in London
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Swiss pharma hopes to bounce back from Q1 sales disappointment
More good news for AbbVie in rheumatoid arthritis
AbbVie has reported positive top-line results for its oral JAK1-selective inhibitor in rheumatoid arthritis (RA), bringing it closer to a potential new early treatment option for patients.
